Characteristic | Men | Women |
---|---|---|
Sex distributiona | 43.3 (1813) | 56.7 (2373) |
BMIb (kg/m2) | 27.2 (4.1) | 26.3 (5.0) |
LTPA frequency (times/week) | ||
< 1a | 29.8 (540) | 23.2 (550) |
1a | 21.0 (381) | 22.7 (538) |
2–3a | 34.4 (624) | 37.5 (891) |
≥ 4–6a | 14.8 (268) | 16.6 (394) |
Smoking status | ||
Non-smokera | 46.9 (850) | 57.6 (1367) |
Formera | 31.8 (576) | 25.3 (601) |
Currenta | 21.3 (387) | 17.1 (405) |
HSCL-25c (total mean score) | 1.20 (1.08–1.44) | 1.24 (1.12–1.48) |
Comorbidity associated with ANS function | ||
Noa | 90.3 (1638) | 91.3 (2167) |
Yesa | 9.7 (175) | 8.7 (206) |
Medication associated with ANS function | ||
Noa | 84.5 (1532) | 85.4 (2026) |
Yesa | 15.5 (281) | 14.6 (347) |
Characteristics of musculoskeletal pain | ||
NPSc | 3 (2–5) | 4 (2–5) |
If pain, its intensityc (NRS) | 3 (2–6) | 4 (2–6) |
If pain, its frequency (days/year) | ||
0a | 5.4 (98) | 3.5 (82) |
1–7a | 15.4 (279) | 10.7 (255) |
8–30a | 23.8 (432) | 23.2 (551) |
> 30 but not dailya | 32.2 (583) | 38.1 (904) |
Dailya | 20.5 (371) | 23.5 (557) |
Cardiovascular autonomic function | ||
HRV data (n = 1813 men, n = 2373 women) | ||
HR, seatedc (bpm) | 70.2 (62.8–78.9) | 71.3 (65.0–78.3) |
HR, standingc (bpm) | 80.6 (72.2–89.4) | 82.3 (74.6–90.6) |
rMSSD, seatedc (ms) | 19.9 (13.0–29.8) | 23.8 (15.7–35.1) |
rMSSD, standingc (ms) | 12.6 (8.2–18.5) | 12.8 (8.4–19.2) |
BRS data (n = 919 men, n = 1112 women) | ||
SBPV, seatedc (mmHg2) | 5.70 (3.37–9.48) | 5.46 (3.00–9.04) |
SBPV, standingc (mmHg2) | 9.00 (5.07–15.83) | 7.55 (4.21–12.65) |
BRS, seatedc (ms/mmHg) | 6.57 (4.76–9.35) | 6.22 (4.41–8.49) |
BRS, standingc (ms/mmHg) | 4.75 (3.22–6.67) | 4.16 (3.01–5.90) |